WRN Promoter CpG island hypermethylation does not predict a favourable outcome for irinotecan-treated metastatic colorectal cancer patients
- Author
- LJW Bosch, Y Luo, VV Lao, P Snaebjornsson, Geert Trooskens (UGent) , I Vlassenbroeck, S Mongera, W Tang, P Welcsh, J Herman, M Koopman, I Nagtegaal, CJA Punt, Wim Van Criekinge (UGent) , GA Meijer, RJ Monnat, B Carvalho and WM Grady
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-7154430
- MLA
- Bosch, LJW, et al. “WRN Promoter CpG Island Hypermethylation Does Not Predict a Favourable Outcome for Irinotecan-Treated Metastatic Colorectal Cancer Patients.” JOURNAL OF PATHOLOGY, vol. 237, no. suppl. 1, 2015, pp. S40–S40.
- APA
- Bosch, L., Luo, Y., Lao, V., Snaebjornsson, P., Trooskens, G., Vlassenbroeck, I., … Grady, W. (2015). WRN Promoter CpG island hypermethylation does not predict a favourable outcome for irinotecan-treated metastatic colorectal cancer patients. JOURNAL OF PATHOLOGY, 237(suppl. 1), S40–S40.
- Chicago author-date
- Bosch, LJW, Y Luo, VV Lao, P Snaebjornsson, Geert Trooskens, I Vlassenbroeck, S Mongera, et al. 2015. “WRN Promoter CpG Island Hypermethylation Does Not Predict a Favourable Outcome for Irinotecan-Treated Metastatic Colorectal Cancer Patients.” In JOURNAL OF PATHOLOGY, 237:S40–S40.
- Chicago author-date (all authors)
- Bosch, LJW, Y Luo, VV Lao, P Snaebjornsson, Geert Trooskens, I Vlassenbroeck, S Mongera, W Tang, P Welcsh, J Herman, M Koopman, I Nagtegaal, CJA Punt, Wim Van Criekinge, GA Meijer, RJ Monnat, B Carvalho, and WM Grady. 2015. “WRN Promoter CpG Island Hypermethylation Does Not Predict a Favourable Outcome for Irinotecan-Treated Metastatic Colorectal Cancer Patients.” In JOURNAL OF PATHOLOGY, 237:S40–S40.
- Vancouver
- 1.Bosch L, Luo Y, Lao V, Snaebjornsson P, Trooskens G, Vlassenbroeck I, et al. WRN Promoter CpG island hypermethylation does not predict a favourable outcome for irinotecan-treated metastatic colorectal cancer patients. In: JOURNAL OF PATHOLOGY. 2015. p. S40–S40.
- IEEE
- [1]L. Bosch et al., “WRN Promoter CpG island hypermethylation does not predict a favourable outcome for irinotecan-treated metastatic colorectal cancer patients,” in JOURNAL OF PATHOLOGY, Dublin, Ireland, 2015, vol. 237, no. suppl. 1, pp. S40–S40.
@inproceedings{7154430, author = {{Bosch, LJW and Luo, Y and Lao, VV and Snaebjornsson, P and Trooskens, Geert and Vlassenbroeck, I and Mongera, S and Tang, W and Welcsh, P and Herman, J and Koopman, M and Nagtegaal, I and Punt, CJA and Van Criekinge, Wim and Meijer, GA and Monnat, RJ and Carvalho, B and Grady, WM}}, booktitle = {{JOURNAL OF PATHOLOGY}}, issn = {{0022-3417}}, language = {{eng}}, location = {{Dublin, Ireland}}, number = {{suppl. 1}}, pages = {{S40--S40}}, title = {{WRN Promoter CpG island hypermethylation does not predict a favourable outcome for irinotecan-treated metastatic colorectal cancer patients}}, volume = {{237}}, year = {{2015}}, }